- Home
- EM vs NVCT Comparison
EM vs NVCT Comparison
Compare EM & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EM | NVCT |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.7M | 274.5M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EM | NVCT |
|---|---|---|
| Price | $1.20 | $9.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.25 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.3M | 113.0K |
| Earning Date | 06-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $5.55 |
| 52 Week High | $1.46 | $13.34 |
Technical Indicators
Market Signals| Indicator | EM | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 66.07 | 46.41 |
| Support Level | $1.16 | $7.79 |
| Resistance Level | $1.42 | $13.34 |
| Average True Range (ATR) | 0.02 | 0.90 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 73.68 | 0.67 |
Price Performance
Historical ComparisonAbout EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.